Fangfang Li
Fangfang Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jianguo Niu
I. M. System Group Inc. at NOAA, College Park, MD 20740 USA
1 shared publication - Lijuan Wu
School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
1 shared publication - Lin Lu
Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, P. R. China
1 shared publication - Lin-Hua Jiang
Department of Physiology and Pathophysiology and Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Henan Medical University
1 shared publication - Min Xu
Department of Biophysics
1 shared publication - Qiuyuan Fang
Department of Biophysics
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Deficiency of ROS‐Activated TRPM2 Channel Protects Neurons from Cerebral Ischemia‐Reperfusion Injury through Upregulating Autophagy
Cerebral ischemia‐reperfusion (I‐R) transiently increased autophagy by producing excessively reactive oxygen species (ROS); on the other hand, activated autophagy would remove ROS‐damaged mitochondria and proteins, which led to cell survival. However, the regulation mechanism of autophagy activity during cerebral I‐R is still unclear. In this study, we found that deficiency of the TRPM2 channel which is a ROS sensor significantly decreased I‐R‐induced neuronal damage. I‐R transiently increased autophagy activity both in vitro and in vivo. More importantly, TRPM2 deficiency decreased I‐R‐induced neurological deficit score and infarct volume. Interestingly, our results indicated that TRPM2 deficiency could further activate AMPK rather than Beclin1 activity, suggesting that TRPM2 inhibits autophagy by regulating the AMPK/mTOR pathway in I‐R. In conclusion, our study reveals that ROS‐activated TRPM2 inhibits autophagy by downregulating the AMPK/mTOR pathway, which results in neuronal death induced by cerebral I‐R, further supporting that TRPM2 might be a potential drug target for cerebral ischemic injury therapy.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessDeficiency of ROS‐Activated TRPM2 Channel Protects Neurons from Cerebral Ischemia‐Reperfusion Injury through Upregulating Autophagy
Cerebral ischemia‐reperfusion (I‐R) transiently increased autophagy by producing excessively reactive oxygen species (ROS); on the other hand, activated autophagy would remove ROS‐damaged mitochondria and proteins, which led to cell survival. However, the regulation mechanism of autophagy activity during cerebral I‐R is still unclear. In this study, we found that deficiency of the TRPM2 channel which is a ROS sensor significantly decreased I‐R‐induced neuronal damage. I‐R transiently increased autophagy activity both in vitro and in vivo. More importantly, TRPM2 deficiency decreased I‐R‐induced neurological deficit score and infarct volume. Interestingly, our results indicated that TRPM2 deficiency could further activate AMPK rather than Beclin1 activity, suggesting that TRPM2 inhibits autophagy by regulating the AMPK/mTOR pathway in I‐R. In conclusion, our study reveals that ROS‐activated TRPM2 inhibits autophagy by downregulating the AMPK/mTOR pathway, which results in neuronal death induced by cerebral I‐R, further supporting that TRPM2 might be a potential drug target for cerebral ischemic injury therapy.